US equities
|
SPCX
$161.85
▲+9.51%
MU
$909.12
▲+1.46%
TSLA
$385.64
▲+3.19%
NVDA
$219.92
▲+1.59%
SNDK
$1,376.19
▲+0.79%
META
$709.14
▲+2.15%
GOOGL
$332.48
▼-2.29%
AMD
$545.87
▲+2.08%
SPCX
$161.85
▲+9.51%
MU
$909.12
▲+1.46%
TSLA
$385.64
▲+3.19%
NVDA
$219.92
▲+1.59%
SNDK
$1,376.19
▲+0.79%
META
$709.14
▲+2.15%
GOOGL
$332.48
▼-2.29%
AMD
$545.87
▲+2.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:EDIT,NASDAQ:NTLA
Recent news which mentions NASDAQ:EDIT,NASDAQ:NTLA
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
EDIT
NASDAQ:EDIT,NASDAQ:NTLA
NTLA
From
InvestorPlace